Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:phosphate_binder |
| gptkbp:approvedBy |
gptkb:FDA
2013 |
| gptkbp:ATCCode |
gptkb:V03AE05
|
| gptkbp:brand |
gptkb:Velphoro
|
| gptkbp:chemicalFormula |
FeO(OH)·sucrose
|
| gptkbp:developedBy |
gptkb:Vifor_Pharma
|
| gptkbp:eliminatedIn |
fecal
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
binds dietary phosphate in the gut
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea discolored feces |
| gptkbp:usedFor |
hyperphosphatemia in chronic kidney disease
|
| gptkbp:bfsParent |
gptkb:Velphoro
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
sucroferric oxyhydroxide
|